STAT3 as Biologically Relevant Target in H3K27M-Mutant Diffuse Midline Glioma | Oncotarget 

Oncotarget #published this #editorial perspective on October 4, 2023 in Volume 14, entitled, “STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma” by researchers from the Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. ‪@MayoClinic‬
#cancer #glioma #dmg #brain #tumor #openaccess #openscience #peerreview #cancerresearch #perspective #research #journal #publication #meded #publishing
DOI - doi.org/10.18632/oncotarget.2...
Correspondence to - David J. Daniels - daniels.david@mayo.edu
Sign up for free Altmetric alerts about this article - oncotarget.altmetric.com/deta...
Subscribe for free publication alerts from Oncotarget - www.oncotarget.com/subscribe/
Keywords - cancer, H3K27M, DMG, DIPG, midline glioma, STAT3
About Oncotarget
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, please visit www.oncotarget.com and connect with us:
SoundCloud - / oncotarget
Facebook - / oncotarget
X - / oncotarget
Instagram - / oncotargetjrnl
RU-vid - / @oncotargetjournal
LinkedIn - / oncotarget
Pinterest - / oncotarget
Reddit - / oncotarget
Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957

Наука